Berman Tabacco

Recent News

SAVA: Berman Tabacco Alerts Investors with Losses Over $200,000 in Cassava Sciences, Inc. of Approaching Lead Plaintiff Deadline

Boston, Massachusetts--(Newsfile Corp. - September 22, 2021) - Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations by Cassava Sciences, Inc. ("Cassava" or the "Company") (NASDAQ: SAVA), a drug development company. About the Securities Class Action FiledOn August 27, 2021, a securities class action complaint was filed in the Western District of Texas on behalf of purchasers of Cassava common stock between February 2, 2021 and August...

2021-09-22 4:15 PM EDT

SESN: Berman Tabacco Alerts Investors with Losses over $50,000 in Sesen Bio, Inc. of Approaching Lead Plaintiff Deadline

Boston, Massachusetts--(Newsfile Corp. - September 22, 2021) - The Massachusetts office of Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations by Sesen Bio, Inc. ("Sesen Bio" or the "Company") (NASDAQ: SESN), a late-stage clinical company with headquarters in Cambridge, Massachusetts.About the Securities Class Action FiledOn August 19, 2021, a class action was filed against Sesen Bio in the Southern District of New York on behalf of...

2021-09-22 4:15 PM EDT

BLI Alert: Berman Tabacco Announces Investigation of Berkeley Lights, Inc. for Potential Securities Law Violations

Boston, Massachusetts--(Newsfile Corp. - September 16, 2021) - Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations against Berkeley Lights, Inc. (NASDAQ: BLI) ("Berkeley Lights" or the "Company"), a "digital cell biology company" with headquarters in Emeryville, California.In July 2020, Berkeley Lights closed its initial public offering ("IPO"), in which the Company sold 9,315,000 shares of common stock (which included 1,215,000...

2021-09-16 4:15 PM EDT

Berman Tabacco Investigates Potential Securities Claims Against Berkeley Lights, Inc. (BLI)

Boston, Massachusetts--(Newsfile Corp. - September 15, 2021) - Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations against Berkeley Lights, Inc. (NASDAQ: BLI) ("Berkeley Lights" or the "Company"), a "digital cell biology company" with headquarters in Emeryville, California. In July 2020, Berkeley Lights closed its initial public offering ("IPO"), in which the Company sold 9,315,000 shares of common stock (which included 1,215,000...

2021-09-15 3:56 PM EDT

Berman Tabacco Announces Upcoming Lead Plaintiff Deadline for Investors with Significant Losses in Zymergen Inc. (ZY)

Boston, Massachusetts--(Newsfile Corp. - September 14, 2021) - Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations against Zymergen Inc. ("Zymergen" or the "Company") (NASDAQ: ZY), a "biofacturing" company with headquarters in Emeryville, California.If you purchased Zymergen common stock and have sustained losses in excess of $50,000 and are interested in learning more about serving as Lead Plaintiff, please provide your information...

2021-09-14 12:27 PM EDT

Berman Tabacco Announces Upcoming Lead Plaintiff Deadline for Investors with Significant Losses in Sesen Bio, Inc. (SESN)

Boston, Massachusetts--(Newsfile Corp. - September 14, 2021) - The Massachusetts office of Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations by Sesen Bio, Inc. ("Sesen Bio" or the "Company") (NASDAQ: SESN), a late-stage clinical company with headquarters in Cambridge, Massachusetts.If you sustained losses in excess of $50,000 from your transactions in Sesen Bio securities during the Class Period (as defined below) and are...

2021-09-14 12:26 PM EDT

Berman Tabacco Alerts Investors with Losses Over $200,000 in Cassava Sciences, Inc. (SAVA) of Approaching Lead Plaintiff Deadline

Boston, Massachusetts--(Newsfile Corp. - September 14, 2021) - Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations by Cassava Sciences, Inc. ("Cassava" or the "Company") (NASDAQ: SAVA), a drug development company.About the Securities Class Action FiledOn August 27, 2021, a securities class action complaint was filed in the Western District of Texas on behalf of purchasers of Cassava common stock between February 2, 2021 and August...

2021-09-14 12:24 PM EDT

Berman Tabacco Alerts Investors with Losses Over $200,000 of Deadline for Seeking Appointment as Lead Plaintiff in Cassava Sciences, Inc. (SAVA)

Boston, Massachusetts--(Newsfile Corp. - September 7, 2021) - Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations by Cassava Sciences, Inc. ("Cassava" or the "Company") (NASDAQ: SAVA), a drug development company. About the Securities Class Action FiledOn August 27, 2021, a securities class action complaint was filed in the Western District of Texas on behalf of purchasers of Cassava common stock between February 2, 2021 and August...

2021-09-07 12:53 PM EDT

Berman Tabacco Alerts Investors with Losses in Excess of $50,000 of Approaching Lead Plaintiff Deadline in Class Action Filed Against Stable Road Acquisition Corp. (SRAC, SRACU, SRACW)

Boston, Massachusetts--(Newsfile Corp. - September 7, 2021) - Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations against Stable Road Acquisition Corp. ("Stable Road" or the "Company") (NASDAQ: SRAC) (NASDAQ: SRACU) (NASDAQ: SRACW) in connection with its proposed combination with Momentus, Inc. ("Momentus").If you purchased Stable Road common stock and have sustained losses in excess of $50,000 and are interested in learning more...

2021-09-07 12:50 PM EDT

Berman Tabacco Alerts Investors with Losses Over $50,000 of Deadline for Seeking Appointment as Lead Plaintiff in Against Zymergen Inc. (ZY)

Boston, Massachusetts--(Newsfile Corp. - September 7, 2021) - Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations against Zymergen Inc. ("Zymergen" or the "Company") (NASDAQ: ZY), a "biofacturing" company with headquarters in Emeryville, California. If you purchased Zymergen common stock and have sustained losses in excess of $50,000 and are interested in learning more about serving as Lead Plaintiff, please provide your information...

2021-09-07 12:47 PM EDT

Berman Tabacco Alerts Investors with Losses Over $50,000 of Deadline for Seeking Appointment as Lead Plaintiff in Sesen Bio, Inc. (SESN) Class Action

Boston, Massachusetts--(Newsfile Corp. - September 7, 2021) - The Massachusetts office of Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations by Sesen Bio, Inc. ("Sesen Bio" or the "Company") (NASDAQ: SESN), a late-stage clinical company with headquarters in Cambridge, Massachusetts.If you sustained losses in excess of $50,000 from your transactions in Sesen Bio securities during the Class Period (as defined below) and are...

2021-09-07 12:45 PM EDT

SAVA DEADLINE: Berman Tabacco Alerts Investors with Losses In Excess of $200,000 of Deadline for Seeking Appointment as Lead Plaintiff in Cassava Sciences, Inc. Class Action

Boston, Massachusetts--(Newsfile Corp. - September 3, 2021) - Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations by Cassava Sciences, Inc. ("Cassava" or the "Company") (NASDAQ: SAVA), a drug development company.About the Securities Class Action FiledOn August 27, 2021, a securities class action complaint was filed in the Western District of Texas on behalf of purchasers of Cassava common stock between February 2, 2021 and August...

2021-09-03 2:03 PM EDT

SAVA ALERT: Berman Tabacco Announces Approaching Lead Plaintiff Deadline for Cassava Sciences, Inc. Investors with Losses in Excess of $100,000

Boston, Massachusetts--(Newsfile Corp. - September 1, 2021) - Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations by Cassava Sciences, Inc. ("Cassava" or the "Company") (NASDAQ: SAVA), a drug development company.About the Securities Class Action FiledOn August 27, 2021, a securities class action complaint was filed in the Western District of Texas on behalf of purchasers of Cassava common stock between February 2, 2021 and August...

2021-09-01 5:15 PM EDT

Berman Tabacco Announces Approaching Lead Plaintiff Deadline for Investors with Losses in Excess of $100,000 from Cassava Sciences, Inc.

Boston, Massachusetts--(Newsfile Corp. - August 30, 2021) - Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations by Cassava Sciences, Inc. ("Cassava" or the "Company") (NASDAQ: SAVA), a drug development company. About the Securities Class Action FiledOn August 27, 2021, a securities class action complaint was filed in the Western District of Texas on behalf of purchasers of Cassava common stock between February 2, 2021 and August 24,...

2021-08-30 12:03 PM EDT

ZY ALERT: Berman Tabacco Alerts Investors with Losses in Excess of $50,000 of Approaching Lead Plaintiff Deadline in Lawsuit Filed Against Zymergen Inc.

Boston, Massachusetts--(Newsfile Corp. - August 27, 2021) - Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations against Zymergen Inc. ("Zymergen" or the "Company") (NASDAQ: ZY), a "biofacturing" company with headquarters in Emeryville, California.If you purchased Zymergen common stock and have sustained losses in excess of $50,000 and are interested in learning more about serving as Lead Plaintiff, please provide your information...

2021-08-27 5:30 PM EDT

SESN: Berman Tabacco Alerts Investors with Losses Over $50,000 from Investments in Sesen Bio, Inc. of Upcoming Lead Plaintiff Deadline

Boston, Massachusetts--(Newsfile Corp. - August 27, 2021) - The Massachusetts office of Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations by Sesen Bio, Inc. ("Sesen Bio" or the "Company") (NASDAQ: SESN), a late-stage clinical company with headquarters in Cambridge, Massachusetts.If you sustained losses in excess of $50,000 from your transactions in Sesen Bio securities during the Class Period (as defined below) and are interested...

2021-08-27 5:30 PM EDT

SAVA: Berman Tabacco Alerts Investors with Losses of $100,000 from Investments in Cassava Sciences, Inc. of Deadline to Apply to Serve as Lead Plaintiff

Boston, Massachusetts--(Newsfile Corp. - August 27, 2021) - Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations by Cassava Sciences, Inc. ("Cassava" or the "Company") (NASDAQ: SAVA), a drug development company. If you sustained losses in excess of $100,000 from your transactions in Cassava securities during the Class Period and are interested in learning more about serving as Lead Plaintiff, please provide your information here:...

2021-08-27 4:09 PM EDT

SAVA Alert: Berman Tabacco Investigates Cassava Sciences, Inc. for Potential Securities Claims in Connection with FDA Citizen Petition

Boston, Massachusetts--(Newsfile Corp. - August 26, 2021) - Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations by Cassava Sciences, Inc. ("Cassava" or the "Company") (NASDAQ: SAVA), a drug development company.On August 25, 2021, Bloomberg reported that shares of Cassava were down 31% "after a lawyer sought to stop studies of the biotech company's experimental treatment for Alzheimer's disease." According to Bloomberg, "a citizen...

2021-08-26 2:10 PM EDT

Berman Tabacco Announces that Investors with Substantial Losses in Sesen Bio, Inc. May Seek Appointment as Lead Plaintiff

Boston, Massachusetts--(Newsfile Corp. - August 25, 2021) - The Massachusetts office of Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations by Sesen Bio, Inc. ("Sesen Bio" or the "Company") (NASDAQ: SESN), a late-stage clinical company with headquarters in Cambridge, Massachusetts.About the Securities Class Action FiledOn August 19, 2021, a class action was filed against Sesen Bio in the Southern District of New York on behalf of...

2021-08-25 4:09 PM EDT

Shareholder Alert: Berman Tabacco Announces Investigation of Cassava Sciences, Inc. (SAVA) for Potential Securities Law Violations

Boston, Massachusetts--(Newsfile Corp. - August 25, 2021) - Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations by Cassava Sciences, Inc. ("Cassava" or the "Company") (NASDAQ: SAVA), a drug development company. On August 25, 2021, Bloomberg reported that shares of Cassava were down over 20% in pre-market trading "after a lawyer asked the FDA to halt the company's clinical trials of an experimental drug, citing concerns about the...

2021-08-25 11:00 AM EDT

Ready to Announce with Confidence?

Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us